TauRx Therapeutics announced today that enough subjects have been enrolled in the second of two phase III clinical trials to continue validating a tau aggregation inhibitor called LMTX for the treatment of mild Alzheimer's disease.

The University of Maryland announced this month that 18 projects with a value of $4.7 million have been approved through the Maryland Industrial Partnership (MIPS) program, which is fostered by the Maryland Technology Enterprise Institute and A. James Clark School of Engineering. Projects include the development of cancer therapeutics and motion correction software for brain PET systems.

This year’s World Molecular Imaging Congress (WMIC), the Annual Meeting of the World Molecular Imaging Society (WMIS), brought the most cutting edge research and technology in preclinical research and molecular imaging technology to the World Trade Center in Seoul, Korea, from Sept. 17-20.

Mediso Medical Equipment Developing and Service Ltd. is proud to announce the hundred and fiftieth installation of Mediso manufactured, integrated preclinical imaging systems, at the prestigious Edinburgh University.

Despite the considerable progress that’s been made to bridge the gap between IT and radiology, in part through the development of sophisticated IT-based radiology practice solutions, a considerable understanding gap remains between those who implement and support solutions and those who use them.  According to results from a recent survey conducted by Adam H. Kaye, MD, MBA, of the Hospital of the University of Pennsylvania, and presented at the 2014 annual meeting of the Society of Imaging Informatics in Medicine (SIIM), individuals from IT and radiology staff working in the same facility feel like fish out of water when asked about the specific day-to-day workflows and decision-making processes of the other group. After completing a survey and participating in a shadowing experiment, the two groups gained alignment, achieved only because they were able to experience and understand the needs of the other group and recognize the importance of communication. 

Navidea, based in Dublin, Ohio, announced yesterday that the radiopharmaceutical company has received orphan drug designation for the small molecular radiotracer technetium-99m tilmanocept (Lymphoseek) specifically for sentinel lymph node mapping in cancer cases of the head and neck.

Quantitative PET metrics including metabolic tumor volume using F-18 FDG can project heath outcomes after chemoradiotherapy for patients with non-small cell lung cancer (NSCLC), according to a study presented Wednesday during the 2014 Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) held Sept. 14-17 at the Moscone Center in San Francisco.

External beam radiotherapy (EBRT) was compared with a combination therapy of EBRT and brachytherapy to see which provided long-term sexual health for patients with prostate cancer. Results indicated that both treatment plans led to a high level of sexual function due to isolated radiation, according to a study presented during the 2014 annual meeting of the American Society for Radiation Oncology (ASTRO) being held Sept. 14-17 at the Moscone Center in San Francisco.